These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33574718)

  • 21. The Brief Obsessive-Compulsive Scale (BOCS): a self-report scale for OCD and obsessive-compulsive related disorders.
    Bejerot S; Edman G; Anckarsäter H; Berglund G; Gillberg C; Hofvander B; Humble MB; Mörtberg E; Råstam M; Ståhlberg O; Frisén L
    Nord J Psychiatry; 2014 Nov; 68(8):549-59. PubMed ID: 24568661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of Intensive Cognitive Behaviour Therapy in a Residential Setting for People with Severe Obsessive Compulsive Disorder: A Large Open Case Series.
    Veale D; Naismith I; Miles S; Childs G; Ball J; Muccio F; Darnley S
    Behav Cogn Psychother; 2016 May; 44(3):331-46. PubMed ID: 26122913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are trauma and dissociation related to treatment resistance in patients with obsessive-compulsive disorder?
    Semiz UB; Inanc L; Bezgin CH
    Soc Psychiatry Psychiatr Epidemiol; 2014 Aug; 49(8):1287-96. PubMed ID: 24213522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A standardized cognitive-behavioural group treatment program for obsessive compulsive disorder: preliminary outcomes].
    Bouvard M
    Encephale; 2002; 28(5 Pt 1):439-46. PubMed ID: 12386546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in obsessive-compulsive disorder patients.
    Kawano A; Tanaka Y; Ishitobi Y; Maruyama Y; Ando T; Inoue A; Okamoto S; Imanaga J; Kanehisa M; Higuma H; Ninomiya T; Tsuru J; Akiyoshi J
    Psychiatry Res; 2013 Aug; 209(1):85-90. PubMed ID: 23266021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of personality traits on ratings of obsessive-compulsive symptoms.
    Huh MJ; Shim G; Byun MS; Kim SN; Kim E; Jang JH; Shin MS; Kwon JS
    Psychiatry Investig; 2013 Sep; 10(3):259-65. PubMed ID: 24302949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent validity of the Yale-Brown Obsessive-Compulsive Scale-Symptom Checklist.
    Sulkowski ML; Storch EA; Geffken GR; Ricketts E; Murphy TK; Goodman WK
    J Clin Psychol; 2008 Dec; 64(12):1338-51. PubMed ID: 18942133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severity of panic disorder, adverse events in childhood, dissociation, self-stigma and comorbid personality disorders Part 1: Relationships between clinical, psychosocial and demographic factors in pharmacoresistant panic disorder patients.
    Kolek A; Prasko J; Vanek J; Kantor K; Holubova M; Slepecky M; Nesnidal V; Latalova K; Ociskova M; Grambal A
    Neuro Endocrinol Lett; 2019 Dec; 40(5):233-246. PubMed ID: 32112548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining clinical severity in adults with obsessive-compulsive disorder.
    Storch EA; De Nadai AS; Conceição do Rosário M; Shavitt RG; Torres AR; Ferrão YA; Miguel EC; Lewin AB; Fontenelle LF
    Compr Psychiatry; 2015 Nov; 63():30-5. PubMed ID: 26555489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Effectiveness and Cost-Effectiveness of Videoconference-Delivered Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder, Panic Disorder, and Social Anxiety Disorder in Japan: One-Year Follow-Up of a Single-Arm Trial.
    Matsumoto K; Hamatani S; Nagai K; Sutoh C; Nakagawa A; Shimizu E
    JMIR Ment Health; 2020 Apr; 7(4):e17157. PubMed ID: 32324150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of cognitive behavioural therapy with medication for patients with obsessive-compulsive disorder: A multicentre randomised controlled trial in China.
    Meng FQ; Han HY; Luo J; Liu J; Liu ZR; Tang Y; Hou X; Wei J; Shi LL; Tang MN; Yan YP; Huang YQ; Sun J; Li ZJ
    J Affect Disord; 2019 Jun; 253():184-192. PubMed ID: 31108379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Body dysmorphic disorder in patients with obsessive-compulsive disorder: prevalence and clinical correlates.
    Conceição Costa DL; Chagas Assunção M; Arzeno Ferrão Y; Archetti Conrado L; Hajaj Gonzalez C; Franklin Fontenelle L; Fossaluza V; Constantino Miguel E; Rodrigues Torres A; Gedanke Shavitt R
    Depress Anxiety; 2012 Nov; 29(11):966-75. PubMed ID: 22815241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in obsessive-compulsive symptom dimensions between patients with epilepsy with obsessive-compulsive symptoms and patients with OCD.
    Kilicaslan EE; Türe HS; Kasal Mİ; Çavuş NN; Akyüz DA; Akhan G; Besiroglu L
    Epilepsy Behav; 2020 Jan; 102():106640. PubMed ID: 31805512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of obsessive-compulsive disorder complicated by comorbid eating disorders.
    Simpson HB; Wetterneck CT; Cahill SP; Steinglass JE; Franklin ME; Leonard RC; Weltzin TE; Riemann BC
    Cogn Behav Ther; 2013; 42(1):64-76. PubMed ID: 23316878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-sectional study of internalised stigma and medication adherence in patients with obsessive compulsive disorder.
    Ansari E; Mishra S; Tripathi A; Kar SK; Dalal PK
    Gen Psychiatr; 2020; 33(2):e100180. PubMed ID: 32215363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and clinical predictors of response to rTMS treatment in pharmacoresistant obsessive-compulsive disorder (OCD): a retrospective study.
    Rostami R; Kazemi R; Jabbari A; Madani AS; Rostami H; Taherpour MA; Molavi P; Jaafari N; Kuo MF; Vicario CM; Nitsche MA; Salehinejad MA
    BMC Psychiatry; 2020 Jul; 20(1):372. PubMed ID: 32677923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between severity of obsessive-compulsive symptoms and schizotypy in obsessive-compulsive disorder.
    Yamamoto H; Tsuchida H; Nakamae T; Nishida S; Sakai Y; Fujimori A; Narumoto J; Wada Y; Yoshida T; Taga C; Fukui K
    Neuropsychiatr Dis Treat; 2012; 8():579-83. PubMed ID: 23248572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Criterion Validity of the Yale-Brown Obsessive-Compulsive Scale Second Edition for Diagnosis of Obsessive-Compulsive Disorder in Adults.
    Castro-Rodrigues P; Camacho M; Almeida S; Marinho M; Soares C; Barahona-Corrêa JB; Oliveira-Maia AJ
    Front Psychiatry; 2018; 9():431. PubMed ID: 30254588
    [No Abstract]   [Full Text] [Related]  

  • 39. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions.
    Rosario-Campos MC; Miguel EC; Quatrano S; Chacon P; Ferrao Y; Findley D; Katsovich L; Scahill L; King RA; Woody SR; Tolin D; Hollander E; Kano Y; Leckman JF
    Mol Psychiatry; 2006 May; 11(5):495-504. PubMed ID: 16432526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive-Behavioral Therapy Versus Transcranial Direct Current Stimulation for Augmenting Selective Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder Patients.
    Dadashi M; Yousefi Asl V; Morsali Y
    Basic Clin Neurosci; 2020; 11(1):111-120. PubMed ID: 32483481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.